Join us for a discussion on a novel antipsychotic that is in development for the treatment of schizophrenia, KarXT. This unique medication uses a combination of central muscarinic agonism and peripheral antagonism.
Join us as we take a break from some psychopharmacology. Today, we will be talking about CBT-I, one of the first-line therapy interventions for insomnia.